DRUG PRODUCT DEVELOPMENT & MANUFACTURING
Across oral, nasal, pulmonary and sterile drug products, we step up where others turn away.
We provide fully integrated CDMO services across every stage of drug product development from
early feasibility through to clinical manufacturing and commercial supply.
Most CDMOs hand your programme on. Between phases, between teams, between sites - knowledge gets lost, decisions get repeated, and momentum stalls.
Upperton is structured differently.
One iste, senior scientists and leadership who stay close to your molecule from first formulation to final product. R&D, GMP and QC operating without handovers, without gaps, and without the risk that comes from fragmented development.
Your molecule never leaves the hands that understand it. That's not how every CDMO works. It's how we work.
Years of formulation expertise across oral, nasal, pulmonary and parenteral dosage forms.
development and manufacturing facility in Nottingham, UK
Capital invested in our 60,000 sq ft GMP facility at Trent Gateway, Nottingham.
We provide fully integrated services across every stage of drug product development:
Upperton combines advanced formulation expertise, integrated development capabilities, and single-site execution to ensure speed, efficiency, and control at every stage of your drug product journey.
With 25+ years of expertise in dry powder formulations and complex dosage forms, we take full ownership of your molecule’s lifecycle from early-stage development to clinical supply and beyond.




How can we help you?